Skip to main content
EQL Pharma AB logo

EQL Pharma AB — Investor Relations & Filings

Ticker · EQL ISIN · SE0005497732 LEI · 549300Q8B2D2AE8GCW21 ST Manufacturing
Open in API
Filings indexed 57 across all filing types
Latest filing 2025-10-06 Board/Management Inform…
Country SE Sweden
Listing ST EQL

About EQL Pharma AB

https://eqlpharma.com/en/

EQL Pharma AB is a pharmaceutical company that develops, markets, and sells generic and specialty medicines. The company's strategy centers on identifying and developing "niche generics," which are medically equivalent to originator drugs but face limited competition after patent expiration. Its business operations also include specialty pharmaceuticals and the parallel import of medicines. EQL Pharma emphasizes cost-efficiency and collaborates with a global network of development partners. The company serves pharmacies and hospitals, primarily in the Nordic markets, maintaining a portfolio of marketed products while cultivating an extensive pipeline of new medicines.

Recent filings

Filing Released Lang Actions
EQL Pharma in process of recruiting new Chief Commercial Officer (CCO)
Board/Management Information Classification · 1% confidence The document is a press release announcing the departure of the current Chief Commercial Officer (CCO) and the ongoing recruitment process for a successor. This falls under the category of changes in senior management.
2025-10-06 English
Ändring av antalet aktier och röster i EQL Pharma AB
Share Issue/Capital Change Classification · 1% confidence The document is a press release from EQL Pharma AB announcing an increase in the total number of shares and votes due to the exercise of warrants. This type of disclosure regarding changes in share capital is classified as a 'Share Issue/Capital Change' announcement.
2025-09-30 Swedish
Change in number of shares and votes in EQL Pharma AB
Share Issue/Capital Change Classification · 1% confidence The document is a press release announcing a change in the total number of shares and votes in EQL Pharma AB due to the exercise of warrants. This type of corporate disclosure regarding changes in share capital structure falls under the category of share issues or capital changes.
2025-09-30 English
Delivery delays mean that the second quarter and thus the full year 2025/26 will be weaker than expected
Earnings Release Classification · 1% confidence The document is a press release issued by EQL Pharma AB regarding a profit warning and updated financial expectations for the second quarter and full year 2025/26. It provides preliminary, unaudited financial figures and explains the reasons for the deviation from previous expectations. Since it is an initial announcement of financial results (key highlights) rather than the full report itself, and it does not fit into specific categories like M&A or dividend announcements, it is classified as an Earnings Release (ER). Q2 2025
2025-09-22 English
Leveransförseningar gör att andra kvartalet och därmed helåret 2025/26 blir svagare än väntat
Earnings Release Classification · 1% confidence The document is a press release from EQL Pharma AB providing a profit warning and updated financial expectations for the second quarter and full fiscal year 2025/26 due to supply chain delays. It explicitly states that the full results will be presented later on November 5, 2025. Since this is an initial announcement of financial performance highlights (profit warning) rather than the full report, it falls under the Earnings Release category. Q2 2025
2025-09-22 Swedish
Kommuniké från årsstämma i EQL Pharma AB den 21 augusti 2025
AGM Information Classification · 1% confidence The document is a 'Kommuniké från årsstämma' (Annual General Meeting Communiqué) from EQL Pharma AB. It details the specific decisions made during the meeting, including the approval of financial statements, discharge of liability for the board and CEO, election of board members and auditors, approval of the remuneration report, and the implementation of a long-term incentive program. This fits the definition of AGM-R (AGM Information/Materials) as it summarizes the proceedings and resolutions of the Annual General Meeting.
2025-08-21 Swedish

Report missing filing

Can't find a specific document? Let us know and we'll add it within 24 hours.

We will notify you once the filing is added.
Report sent
Thank you. We will check the data and update it shortly.